These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6084838)

  • 1. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
    Friedmann W; Steffens J; Lobeck H
    Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
    Steffens J; Friedmann W; Lobeck H
    Eur Urol; 1985; 11(2):91-4. PubMed ID: 2408895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.
    Stein BS; Vangore S; Petersen RO
    Urology; 1984 Aug; 24(2):146-52. PubMed ID: 6205496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic origin of tumors. An immunohistochemical study.
    Nadji M; Tabei SZ; Castro A; Chu TM; Morales AR
    Am J Clin Pathol; 1980 Jun; 73(6):735-9. PubMed ID: 6156593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
    Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
    Shah NT; Tuttle SE; Strobel SL; Gandhi L
    J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine needle aspiration biopsy.
    Katz RL; Raval P; Brooks TE; Ordóñez NG
    Diagn Cytopathol; 1985; 1(1):28-32. PubMed ID: 2424683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
    Svanholm H
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
    Bauer HW
    Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of commercial immunoperoxidase kits in diagnosis of prostate carcinoma.
    Bentz MS; Cohen C; Budgeon LR; Demers LM
    Urology; 1984 Jan; 23(1):75-8. PubMed ID: 6197801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistologic diagnosis of 2 cases of metastatic prostate cancer to breast.
    Naritoku WY; Taylor CR
    J Urol; 1983 Aug; 130(2):365-7. PubMed ID: 6192256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
    Gallee MP; Visser-de Jong E; van der Korput JA; van der Kwast TH; ten Kate FJ; Schroeder FH; Trapman J
    Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical detection of prostate carcinoma].
    Ma WX; Li W
    Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):37-9. PubMed ID: 2476252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic carcinoma in a young adult: a case report].
    Yamamoto S; Senzaki A; Yamagiwa K; Tanaka T; Oda T
    Hinyokika Kiyo; 1990 May; 36(5):617-22. PubMed ID: 1698013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical diagnosis of prostatic cancer with metastasis.
    Li CY; Lam WK; Yam LT
    Cancer; 1980 Aug; 46(4):706-12. PubMed ID: 6156752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three predominant prostatic proteins.
    Abrahamsson PA; Lilja H
    Andrologia; 1990; 22 Suppl 1():122-31. PubMed ID: 1720287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
    Keillor JS; Aterman K
    J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
    Mathieu MC; Caillaud JM
    Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.